India  

ZyCoV-D

Vaccine candidate against COVID-19

ZyCoV-D    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

ZyCoV-D: Vaccine candidate against COVID-19
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council. It is approved for emergency use in India.

0
shares
ShareTweetSavePostSend
 
ZyCoV-D vaccine cost to be decided by Zydus Cadila & govt; likely to be ₹300/dose | Oneindia News [Video]

ZyCoV-D vaccine cost to be decided by Zydus Cadila & govt; likely to be ₹300/dose | Oneindia News

According to government sources, the price of Zydus Cadila’s Covid-19 vaccine ZyCov-D is likely to be ₹300 per dose. #ZydusCadila #ZyCoVD #ZyCoVDPrice

Credit: Oneindia     Duration: 01:38Published

You Might Like


2.37 lakh doses of ZyCoV-D vaccine get CDL clearance


IndiaTimes - Published

Zydus Cadila's Covid vaccine to be administered only to adults as of now: Sources

Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults as of now under the government's..
IndiaTimes - Published

Covid-19: Govt to start vaccination for kids only after nod to Covaxin

Children may have to wait for some more time to get vaccinated against Covid-19 as the government will start immunisation for kids only after Bharat Biotech's Covaxin is approved for use which might..
IndiaTimes - Published

Zydus Cadila to supply 1 crore doses of its 'needle-free' COVID-19 vaccine to govt at this price

The ZyCoV-D vaccine will be given through a needle-free applicator instead of a syringe.
DNA - Published

Covid-19 vaccination: 'No shortage for door-to-door drive'

Ahead of the proposed door to door vaccination drive by the centre, national task force members have ruled out any shortage of vaccines for the drive with nearly 30 crore vaccines to be procured from..
IndiaTimes - Published

Priority list being drawn up of kids with comorbidities for vaccine rollout

A comprehensive priority list of children with comorbidities is being worked out for the combined launch of ZyCoV-D and Covaxin in India, according to a senior official from the Centre’s Covid-19..
IndiaTimes - Published

COVID-19: NITI Aayog member makes BIG announcement on vaccine for kids

Dr VK Paul, Member (Health), Niti Aayog said the ZyCoV-D vaccine administration requires special training.
DNA - Published

60 lakh vaccine doses of ZyCoV-D are ready after production in October: Sources


IndiaTimes - Published

Kids’ vaccine ZyCoV-D to be given to private hospitals too

The needle-free ZyCoV-D vaccine, manufactured by Zydus Cadila, has received emergency use authorisation for being administered to children between 12 and 17 years of age in India. The three-dose..
IndiaTimes - Published

Zydus Cadila’s vaccine rollout likely in 2 weeks, final checks on: NTAGI chief

The much-awaited national rollout of Zydus Cadila’s Covid vaccine, ZyCoV-D, is going to take two more weeks. “Different batches of ZyCoV-D are undergoing a final round of quality checks at the..
IndiaTimes - Published

Zydus Cadila vaccine soon to be included in India's vaccination programme, say govt

Union health secretary Rajesh Bhushan on Thursday said Zydus Cadila's Covid-19 vaccine will soon be introduced in the national vaccination programme. As far as the price of the vaccine at which it will..
IndiaTimes - Published

Centre likely to roll out 1 crore doses of Zydus Cadila's COVID-19 vaccine ZyCoVD by October - All you need to know

On PM Narendra Modi's 71st birthday, India set a new record for single-day vaccinations and administered over 2 crore COVID-19 vaccine doses.
DNA - Published

Govt plans Covid vaccines for comorbid kids aged 12-17 by October-November

The government plans to begin Covid vaccination of children in the 12-17 age group who have co-morbidities like obesity, heart disorders, or immunodeficiency by October-November, official sources said...
IndiaTimes - Published

Zydus Cadila's Covid-19 vaccine can be available from first week of October

The Union government is expecting Zydus Cadila's needle-free Covid-19 vaccine ZyCoV-D to be available from the first week of October. Further, a decision on whether all children or only those with..
IndiaTimes - Published

ZyCoV-D COVID vaccine likely to be available in market by mid to end September: MD Sharvil Patel

The ZyCoV-D COVID-19 vaccine, which received emergency use authorisation from India's drug regulator on Friday, will be available in the market by mid to end September, Zydus Group Managing Director..
DNA - Published

ZyCov-D vaccine will hit markets soon: Union health minister


IndiaTimes - Published

Will take another 4-5 months to publish phase 3 trials data of ZyCoV-D vaccine, says Zydus Group MD


IndiaTimes - Published

A momentous feat: PM Narendra Modi after Zydus Cadila's Covid vaccine gets emergency use authorisation

The department of biotechnology on Friday said indigenously developed Zydus Cadila Covid-19 vaccine ZyCoV-D has received approval for emergency use authorisation from the Drug Controller General of..
IndiaTimes - Published

Zydus Cadila's ZyCoV-D vaccine gets DCGI nod for emergency use for adults, children above 12 yrs

The company said it plans to manufacture 100 million to 120 million doses of ZyCoV-D annually and has started to stockpile the vaccine.
DNA - Published

Covid vaccination for kids may start only by March ’22

Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine..
IndiaTimes - Published

COVID-19 vaccine for children likely by September: AIIMS Chief

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
DNA - Published

DCGI likely to approve Zydus Cadila's vaccine for children above 12 years

Zydus Cadila's COVID-19 vaccine, ZyCov-D, is a three-dose, intradermal vaccine which is applied using the PharmaJet needle-free system
DNA - Published

Zydus seeks nod for world’s first plasmid DNA Covid vax

Homegrown healthcare and pharmaceutical major Zydus Cadila has applied for emergency use authorisation (EUA) to the office of the Drug Controller General of India for ZyCoV-D, its plasmid DNA vaccine..
IndiaTimes - Published

Zydus Cadila likely to seek emergency authorisation for ZyCoV-D Covid-19 vaccine in 7-8 days

Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
IndiaTimes - Published